STOCK TITAN

Cartesian Growth Corp Iii SEC Filings

CGCT NASDAQ

Welcome to our dedicated page for Cartesian Growth Iii SEC filings (Ticker: CGCT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Cartesian Growth Corporation III (NASDAQ: CGCT) files reports and transaction documents with the U.S. Securities and Exchange Commission that detail its activities as a special purpose acquisition company and its proposed Business Combination with Factorial Inc. Through this SEC filings page, readers can review current reports on Form 8-K, registration statements, and proxy materials that describe the structure, terms, and conditions of the transaction.

In a Form 8-K dated December 17, 2025, Cartesian III reported entry into a Business Combination Agreement with Factorial and a merger subsidiary. That filing outlines the planned domestication from the Cayman Islands to Delaware, the conversion of existing Cartesian III shares into New Factorial Series A Common Stock, the renaming of the post-closing entity to Factorial Holdings, Inc., and the subsequent merger in which Factorial becomes a wholly owned subsidiary. It also summarizes shareholder redemption rights, warrant treatment, governance arrangements, and key closing conditions, including Hart-Scott-Rodino clearance and Nasdaq listing approval.

On this page, users can access such 8-Ks along with other periodic and transactional filings to understand how CGCT’s units, Class A ordinary shares, and warrants are treated in the proposed combination. Filings also describe Cartesian III’s status as an emerging growth company and its affiliation with Cartesian Capital Group, LLC.

Stock Titan enhances access to these documents by pairing real-time updates from the SEC’s EDGAR system with AI-powered summaries that highlight the main points of lengthy agreements and disclosures. This helps readers quickly identify sections dealing with shareholder redemptions, exchange ratios, governance terms, and other elements that are central to evaluating Cartesian III’s Business Combination with Factorial.

Rhea-AI Summary

Cartesian Growth Corporation III files an 8-K reporting that Factorial Inc. entered a non-binding MOU with Philenergy Co., Ltd. to explore a strategic manufacturing collaboration to scale Factorial’s Solstice™ all-solid-state battery platform.

The MOU is non-binding and the proposed collaboration is subject to the negotiation and execution of definitive agreements and the satisfaction of customary conditions. The filing also reiterates that Factorial and Cartesian III are pursuing a proposed business combination and intend to file a Form S-4 in connection with that transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
merger
-
Rhea-AI Summary

Cartesian Growth Corporation III filed a Form 8-K describing a new Memorandum of Understanding between its merger partner Factorial Inc., a solid-state battery developer, and South Korea-based Philenergy, a leading battery equipment and infrastructure provider. The non-binding MOU outlines a strategic manufacturing collaboration aimed at accelerating scale-up of Factorial’s Solstice™ all-solid-state battery platform, which is designed to deliver up to 80% higher energy density and stable operation at temperatures up to 90°C.

The collaboration would explore combining Philenergy’s advanced, modular battery production systems with Factorial’s proprietary architecture, potentially supporting faster volume manufacturing and lower environmental impact through dry cathode processes. The filing also reiterates that Cartesian III and Factorial have a Business Combination Agreement dated December 17, 2025 and plan to file a Form S-4 registration statement and proxy/prospectus for shareholder approval of the proposed business combination.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Highbridge Capital Management, LLC filed a Schedule 13G reporting beneficial ownership of 2,000,000 Class A Ordinary Shares of Cartesian Growth Corporation III, representing 7.2% of the class. This percentage is based on 27,600,000 Class A shares outstanding as of November 14, 2025.

Highbridge has sole power to vote and dispose of these 2,000,000 shares, which are directly held by certain Highbridge-managed funds, including Highbridge Tactical Credit Master Fund, L.P. Highbridge certifies the shares were acquired in the ordinary course of business and not for the purpose of influencing control of the issuer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
Rhea-AI Summary

Cartesian Growth Corp III received a beneficial ownership report showing that investment firm Fort Baker Capital Management LP, together with Steven Patrick Pigott and Fort Baker Capital, LLC, holds 2,529,121 Class A ordinary shares. This stake represents 9.2% of the Class A shares, based on 27,600,000 shares outstanding as of November 14, 2025.

The reporting persons share voting and dispositive power over all 2,529,121 shares and report no sole voting or dispositive authority. They state the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Cartesian Growth Corp III, and they expressly disclaim group status and beneficial ownership beyond their pecuniary interest.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC report beneficial ownership of 2,294,432 Class A ordinary shares of Cartesian Growth Corp III, representing 8.3% of the class as of 12/31/2025.

The shares are reported with shared voting and shared dispositive power and no sole voting or dispositive power. The filing states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Cartesian Growth Corp III.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

Barclays PLC filed an amended Schedule 13G reporting beneficial ownership of 4.52% of Cartesian Growth Corp I Class A common stock as of 12/31/2025. Barclays reports sole voting and dispositive power over these shares, with no shared authority.

The filing states the position is held in the ordinary course of business and not for the purpose or effect of changing or influencing control of Cartesian Growth Corp I. Subsidiaries identified in connection with the holdings include Barclays Bank PLC and Barclays Capital Inc.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
Rhea-AI Summary

Picton Mahoney Asset Management has filed an amended Schedule 13G reporting a significant ownership position in Cartesian Growth Corporation III. As of the event date of 12/31/2025, Picton Mahoney beneficially owned 1,400,000 Class A ordinary shares, with sole power to vote and dispose of all of these shares.

This stake represents 5.07% of the Class A ordinary shares, based on 27,600,000 Class A shares outstanding as of November 14, 2025, as referenced from the issuer’s Form 10-Q. Picton Mahoney is identified as a Canadian investment fund manager, and it certifies that it is subject to a foreign regulatory regime comparable to that of a functionally equivalent U.S. institution.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

Cartesian Growth Corporation III and Factorial Inc. have signed a Business Combination Agreement dated December 17, 2025 to pursue a proposed business combination. The transaction will be put to a shareholder vote, and the parties plan to file a Form S-4 registration statement with the SEC that will include a proxy statement/prospectus for CGC shareholders and Factorial stockholders.

The communication highlights that the deal may include a private placement of common stock (a PIPE) and describes extensive forward-looking statements about Factorial’s early-stage solid-state battery business and the combined company. It stresses numerous risks, including deal completion, regulatory approvals, financing, technology development, competition, and broader economic and policy conditions. Investors are urged to read the future S-4, proxy statement/prospectus and related SEC filings carefully once available, and the text clarifies that this is not an offer to sell or a solicitation to buy securities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
merger
-
Rhea-AI Summary

Cartesian Growth Corporation III agreed to merge with Factorial Inc., a solid-state battery company, under a Business Combination Agreement that will take Factorial public through a SPAC transaction. The deal implies a fully diluted equity value of $1,100,000,000 for Factorial and is targeted to close in mid-2026, subject to shareholder approvals, regulatory clearance and other customary conditions.

Before closing, Cartesian will domesticate from the Cayman Islands to Delaware and be renamed Factorial Holdings, Inc., issuing Series A and Series B common stock. All Factorial shares, options and RSUs will convert into equity or awards linked to the new public company based on a defined exchange ratio.

The transaction is supported by a committed PIPE financing of $100,000,000, split between a Sponsor affiliate and an institutional investor, and includes new equity incentive and employee stock purchase plans that initially reserve 15% and 2% of fully diluted shares, respectively, with annual automatic increases after 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
merger
Rhea-AI Summary

Cartesian Growth Corporation III agreed to merge with solid-state battery developer Factorial Inc. in a SPAC business combination valuing Factorial at an implied fully diluted equity value of $1.1 billion. Before closing, CGC will domesticate from the Cayman Islands to Delaware and be renamed Factorial Holdings, Inc., with all existing CGC equity converting into new Series A common stock.

After the merger, Factorial will become a wholly owned subsidiary and its shareholders and founders will receive New Factorial common shares based on an exchange ratio tied to the $1.1 billion valuation. All Factorial options and RSUs will roll into new awards under a New Factorial equity plan.

The transaction is supported by a committed $100 million PIPE split between a sponsor affiliate and an institutional investor, and is targeted to close in mid-2026, subject to shareholder approvals, regulatory clearances, listing of the new shares on Nasdaq and other customary conditions. New long-term incentive and employee stock purchase plans, registration rights, warrant exchanges and staggered board and lock-up structures are also outlined.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

What is the current stock price of Cartesian Growth Iii (CGCT)?

The current stock price of Cartesian Growth Iii (CGCT) is $10.26 as of March 2, 2026.

What is the market cap of Cartesian Growth Iii (CGCT)?

The market cap of Cartesian Growth Iii (CGCT) is approximately 353.6M.

CGCT Rankings

CGCT Stock Data

353.63M
20.50M
Blank Checks
NEW YORK

CGCT RSS Feed